Device firms want FDA to define "new science," validate emerging data

03/11/2010 | Medical Devices Today

Representatives from device companies said the FDA must develop a definition of "new science" before integrating new scientific data with regulatory decisions such as product evaluations and post-market monitoring. They also advised the agency to examine the data before making policy changes. The recommendations are in response to the agency's request for comments on the issue.

View Full Article in:

Medical Devices Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ